Raz Bar-On

GM Nitinotes ISR. I am proud to lead my team in the development of EndoZip™, a novel, fully-automated endoscopic suturing procedure for obesity treatment.

[Raz Bar-On @RazBarOn1]

EndoZip™ is CE marked and approved for commercial use in Europe. In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use.

[Raz Bar-On @RazBarOn1]

Join us at Interdisciplinary Obesity Days 2026 

This year's program puts bariatric endoscopy center stage, with a dedicated EndoBariatric session.

[Raz Bar-On @RazBarOn1]

Come meet our team and see how we're bringing scalable, reproducible endoscopic solutions to obesity care.

📍 Munich, Germany - The Rilano Hotel
🗓️ September 11-12, 2026
🏷️ Booth #4

#IATMUC #ObesityCare #Endoscopy #Nitinotes

[Raz Bar-On @RazBarOn1]

EndoZip™ is CE-marked and approved for commercial use in Europe. In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use.

[Raz Bar-On @RazBarOn1]

Nitinotes will be at the IFSO World Congress 2026 in Toronto.

The congress is the global meeting point for bariatric and metabolic surgeons, with a scientific program focused on current surgical and endoscopic practice.

[Raz Bar-On @RazBarOn1]

Meet the team to discuss the role of automated suturing in the ESG workflow.
📍 Toronto, Canada
🗓️ September 1-4, 2026
🏷️ Booth #40

#IFSO2026 #BariatricSurgery #ObesityCare

[Raz Bar-On @RazBarOn1]

EndoZip™ is CE marked and approved for commercial use in Europe.
In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use.

[Raz Bar-On @RazBarOn1]

Nitinotes extends its sincere thanks to Reem Z. Sharaiha, MD, and the teams at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center following the completion of the first study procedure in the EASE™ IDE trial.

[Raz Bar-On @RazBarOn1]

Thank you for your trust, partnership, and commitment.

Read the full announcement: https://t.co/dR2ufONnHX
#Nitinotes #EndoZip #EASETrial #ESG #BariatricEndoscopy #ObesityCare #WeillCornell

[Raz Bar-On @RazBarOn1]

EndoZip™ is CE marked and approved for commercial use in Europe.
In the United States, EndoZip™ is an investigational device and is limited by Federal (or United States) law to investigational use.

[Raz Bar-On @RazBarOn1]

We are proud to share that Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center are now clinical sites in the pivotal U.S. EASE™ IDE trial.

[Raz Bar-On @RazBarOn1]

Thanks to Dr. Sharaiha, the teams at Weill Cornell and NewYork-Presbyterian, and the Nitinotes team for bringing this study milestone forward.
Read the full announcement: https://t.co/fXBmpbrxYl
#Nitinotes #EndoZip #ESG #EASETrial #BariatricEndoscopy